Verve Ventures is a European venture capital firm and digital startup investment platform based in Switzerland that connects qualified private investors and institutions with curated startup opportunities across Europe. Founded in 2010, it has invested more than €130 million in over 100 startups and maintains a community of about 5,000 investors, including family offices and pension funds. The firm operates a fully digital platform that enables investors to build diversified portfolios with entries starting around €10,000. An investment team based in Zurich, Lausanne, Berlin, Paris, and Cambridge screens thousands of startups annually, selecting the top performers through rigorous due diligence and then sourcing, structuring rounds, and enabling participation in competitive deals. Verve Ventures is backed by Zürcher Kantonalbank, one of Switzerland’s leading banks, underscoring its European footprint and access to a broad network of institutional and private investors. The firm focuses on technology-driven sectors and seeks to broaden access to venture opportunities that have traditionally been opaque, supporting both early- and growth-stage ventures.

The European Innovation Council is a Brussels-based European Union organization established in 2018 to support deep‑tech innovation by helping startups, researchers and technology transfer activities move ideas toward market. It operates a portfolio of programs including Pathfinder, Accelerator, Transition, STEP Scale Up and Pre-Accelerator, and collaborates with partners to provide funding, mentorship and resources across the innovation lifecycle. The council emphasizes high-impact, science‑driven technologies with broad societal benefit and promotes inclusion, with initiatives to involve women‑led projects. It engages the wider ecosystem through awards, events and community initiatives and monitors impact through data platforms. By coordinating with private investors and other stakeholders, it aims to accelerate the scale-up of European deep‑tech firms and strengthen Europe’s position in global technology leadership.

High-Tech Gründerfonds is a Germany-based venture capital firm established in 2005 that funds early-stage technology startups in Germany. Based in Bonn with an office in Berlin, it supports companies across software, information technology, digital and industrial tech, life sciences, chemistry, IoT, energy, and related fields by providing initial capital and subsequent funding, complemented by active guidance from investment managers. The firm typically acts as a lead investor and cooperates with other investors to help portfolio companies advance from concept to market, with a focus on startups that have begun commercial operations. By combining financing with hands-on support, HTGF aims to help high-potential founders develop their technology, validate products, and scale within the German market.

Redalpine Venture Partners is a Zurich-based European venture capital firm established in 2006 with offices in Berlin and London and a presence in San Francisco. It backs seed and early-stage startups across Europe, with a focus on software, fintech, health tech, and science-driven technologies at the intersection of software and biology. The firm combines capital with hands-on operational support, drawing on a diverse team with scientific and business backgrounds to help portfolio companies scale. Its multi-stage investment approach spans Europe, and it manages around one billion dollars in assets under management, supporting portfolio companies through strategic guidance and a wide international network.

VI Partners is a Swiss venture capital firm founded in 2001 and based in Altendorf. It focuses on investments in healthcare, biotechnology, technology and software companies across Switzerland and Europe, including university spin-offs and other promising startups. The firm provides capital, strategic guidance and access to an extensive network to support portfolio companies as they grow, particularly in early stages such as Seed and Series A rounds. With deep sector expertise and experience in board and shareholder discussions, VI Partners aims to contribute to long-term value creation for its portfolio companies.

Founderful is a Zurich-based Swiss venture capital firm focusing on early-stage technology companies in Switzerland. It often acts as the first and lead investor in initial financing rounds, providing capital, strategic guidance, operational support, and access to a broad network of investors to help portfolio companies scale. The firm emphasizes a founder-centric, empathetic approach and supports entrepreneurs from inception toward global market leadership. Founded in the late 2010s, Founderful has backed over 50 startups and 120 founders, reflecting its active role in the Swiss tech ecosystem. Its investment scope includes business and consumer products and services, energy, financial services, software, and materials and resources.

Spicehaus Partners is a Swiss venture capital firm focused on early-stage technology investments in Switzerland, with a particular emphasis on B2B software. Based in Zug, the firm acts as lead investor and partners with portfolio companies to drive growth and digital transformation. It has funded more than 40 companies and has achieved notable exits such as MOVU and Bexio, while backing investments in fintech, proptech, and cybersecurity. The firm combines investment expertise with entrepreneurial experience to support startups on their path to international success and job creation in the Swiss tech ecosystem.

Tenity is a global fintech innovation platform and accelerator that connects early-stage startups with corporations, governments, and investors at the intersection of fintech, AI, and digital assets. It combines innovation services with venture capital to identify emerging trends, co-design pilots, and scale ventures through investment and global networking. With hubs across Europe and Asia and a base in Zurich, Tenity focuses on fintech, insurtech, Web3, and digital health, delivering over 100 innovation programs for corporate clients worldwide and supporting startups seeking funding and partnerships.

b2venture is a European venture capital firm focused on early-stage and growth investments in digital and industrial technology. Headquartered in Saint Gallen, Switzerland, with offices in Berlin, Munich, Luxembourg and Zurich, the firm concentrates on Europe, especially the DACH region, while considering select non-European opportunities. It backs ambitious founders from seed to IPO, typically investing from EUR 250,000 to EUR 5,000,000 with an average around EUR 1,000,000, and emphasizes active, hands-on support through collaboration with Europe’s angel investor community. The portfolio spans sectors including AI, FinTech, healthcare, education, e-commerce, cybersecurity and SaaS, reflecting a focus on B2B and technology-enabled growth across European markets.

EquityPitcher Ventures is a Zurich, Switzerland based venture capital firm that backs seed-stage B2B companies in the DACH region. It focuses on disruptive technologies across sectors such as digital health, ICT, finance, energy and manufacturing, and operates with a diversified investment approach. The firm leverages a broad industry network to accelerate sales and growth for B2B tech startups, providing strategic collaboration and access to its ecosystem, particularly within Switzerland. By supporting entrepreneurs with capital and connections, EquityPitcher Ventures seeks to foster innovation and scale early-stage ventures across the region.

CV VC is a venture capital firm specializing in seed-stage investments in startups that develop artificial intelligence and blockchain technologies across Europe, the United States, and the Middle East. It bases its strategy on three pillars—Digital Finance, Automation, and Intelligent B2B—to back companies poised to transform industries and create new markets. Beyond direct investments, CV VC runs CV Labs, an ecosystem arm that offers acceleration programs, summits, and coworking spaces to support startups, connect them with investors, and foster collaboration. With more than 80 investments to date, CV VC positions itself as an enabler of the AI-native future and a catalyst for innovation within its ecosystem.

Serpentine Ventures is a Swiss venture capital firm and asset manager based in Zurich. Founded in 2019 as the venture arm of the Swiss Ventures Group, it focuses on European technology companies, with emphasis on information technology and software-as-a-service, and a broader interest in deep tech and scalable climate tech. The firm combines hands-on support, market expertise, and a strong professional network to help founders from incorporation through scaling. It maintains an active portfolio across multiple sectors, aiming to back ambitious teams and foster rapid growth and sustainable impact.

Alpana Ventures is a Swiss venture capital firm based in Geneva that focuses on digital transformation and deeptech investments across Europe, North America and Asia-Pacific. Founded in 2016, it supports seed to growth-stage companies by helping embed breakthrough technologies into innovative business models to create lasting value and global market leadership. The firm applies ESG criteria in its investment approach and seeks opportunities across sectors such as healthcare, information technology, finance, enterprise solutions, mobility, cybersecurity, gaming and related fields. It emphasizes sustainability and Cleantech as part of its digital transformation focus and collaborates with entrepreneurs to scale global operations.

Bloomhaus Ventures is a Swiss-based venture capital firm and the venture arm of a Swiss family office. It backs early-stage B2B startups across Europe, with emphasis on the DACH region, in Industrytech, Deeptech (AI, IoT, robotics, blockchain, cybersecurity), and CleanTech. The firm typically supports pre-seed and seed rounds, providing capital and practical assistance such as business strategy, go-to-market and market-entry guidance to help portfolio companies scale. It maintains an international reach, including Switzerland and broader European markets, and seeks long-term partnerships that enable sustainable growth.

TX Ventures is the corporate venture arm of TX Group, based in Zurich, Switzerland. It manages a CHF 100 million fund focused on investing in fintech, insurtech, proptech, cybertech, and digital assets across Europe, including the UK. Beyond capital, TX Ventures provides strategic guidance, access to customers, and hands-on support in marketing, technology, and IT security to portfolio companies, and typically targets seed to Series A rounds of CHF 1-5 million. Portfolio companies include Sinpex, Cashlink, and Trustap.

BioMedPartners is a Switzerland-headquartered venture capital firm focused on life sciences. It targets early- and mid-stage investments in healthcare and human life science companies, including pharmaceuticals, biotechnology, diagnostics and medical technology, with activity across Central Europe and offices in Germany and Guernsey.

ACE & Company is a Geneva-based private equity and venture capital firm founded in 2005. It operates across multiple stages—secondaries, buyouts, and venture investments—and focuses on diversified, stage-aware portfolio construction to optimize risk-adjusted returns. The firm supports investments through ACE Ventures, a team of operators, engineers, and investors delivering hands-on value beyond capital. With offices in Geneva, Zurich, London, New York, and Cairo, ACE & Company pursues opportunities across sectors including healthcare services, information technology, financial services, energy services, and business products and services. It engages in angel, growth, early, mature, buyout, and secondary investments, as well as special situations, tailoring commitments by strategy. The firm has grown to exceed $2 billion in assets under management across its strategies and emphasizes disciplined capital allocation, risk management, and investor alignment.

Swiss Post Ventures is the corporate venture capital arm of Swiss Post based in Bern, Switzerland. It invests in early- and later-stage companies in Switzerland and abroad, and actively engages startups through partnerships, providing funding, market access, and business expertise via initiatives such as Urban Connect and Hacknowledge. It collaborates with a network of external development partners including startups, universities, and other postal organizations to test new technologies and business models across core areas such as communication, logistics, financial services, business process outsourcing, and mobility. An innovation team supports these efforts, with annual and interim reports offering transparency to stakeholders.

Kickfund is a Swiss venture capital firm that invests in deep-tech startups emerging from Swiss academic institutions. It partners with the Venture Kick competition and co-invests up to CHF 850,000 to support early-stage companies, providing strategic guidance and access to a diverse network of mentors and investors. Backed by the Ernst Göhner and Gebert Rüf Foundations, Kickfund aims to strengthen Switzerland’s innovation ecosystem and establish the country as a global hub for deep tech, digital, and life sciences. The firm operates with a systematic investment approach and maintains a portfolio across high-potential ventures, emphasizing scalable solutions and impact.

Blue Horizon Corporation is a Zurich-based venture capital firm founded in 2016 that invests in the agriculture and food ecosystem, including plant-based, food tech, and processing and distribution. It backs early-stage founders and growth-stage roll-ups across the biology, technology, and agriculture spectrum to build sustainable food systems. The firm partners with farmers, food producers, and distributors to scale mission-aligned ventures and pursues a Double Positive approach, aiming for strong financial returns alongside tangible environmental benefits. Blue Horizon maintains a European focus and has backed over 100 companies, including 3 unicorns, with 53% of portfolio companies founded by women. It supports its investments through active involvement and industry insights, helping portfolio companies scale across their lifecycle.

SIX FinTech Ventures is the corporate venture capital arm of SIX Group, based in Zurich, Switzerland. It invests in global early-stage fintech startups from seed to Series A, focusing on wealth management, capital markets, RegTech, and token ecosystems, and leveraging technologies such as blockchain, artificial intelligence, big data, IoT, and AR/VR. The firm targets opportunities in Switzerland, Western Europe, and opportunistically in other regions, with initial tickets typically ranging from CHF 0.2 to 3 million.

Privilège Ventures is a Swiss-based venture capital firm authorized by the Swiss Financial Market Supervisory Authority as a venture capital asset manager. Headquartered in Lugano with offices in Zurich and Boston, it invests in early-stage startups across Europe from pre-seed to Series A, with a focus on HealthTech, CleanTech and AgriFoodTech. The firm provides strategic guidance, industry expertise and access to a broad network to support founders, drawing on a team with deep financial and operational experience to foster growth and long-term value creation.

HBM Healthcare Investments is a Swiss investment company that concentrates on the global healthcare sector, seeking to capitalize on innovation across private and public healthcare companies. Founded in 2001 and based in Switzerland, it maintains a diversified portfolio spanning human medicine, biotechnology, medical technology and diagnostics, with investments across private companies, public equities, and funds. The firm emphasizes high-value creation potential through its portfolio and positions itself to benefit from demographic trends, medical advancements and rising demand for new therapies.

Gimv is a European investment company based in Antwerp, Belgium, focused on private equity and venture capital investments since 1980. It builds a diversified portfolio across sectors including consumer, healthcare, life sciences, smart industries, energy and sustainable cities, with an emphasis on ambitious, innovative companies located in the Benelux, France and the DACH region. The firm operates through dedicated platforms such as Consumer Healthcare, Smart Industries, Sustainable Cities and Anchor investments, pursuing long-term equity investments and value creation through strong management, solid balance sheets and disciplined growth strategies. Its portfolio comprises dozens of companies with a combined turnover measured in the billions and tens of thousands of employees, reflecting Gimvil's approach to partnering with management teams to drive sustainable growth in Europe.

BackBone Ventures is an early-stage venture capital firm founded in 2018 and based in Zurich and Frankfurt. It supports seed and pre-seed companies across information and communications technology, food technology, and disruptive technologies, with investment activity spanning the DACH region and Israel. The firm seeks founders tackling large markets and values entrepreneurs who can progress from concept to growth, aiming to be a trusted partner to both founders and investors. It has a track record of multiple investments and three exits, reflecting a focus on helping portfolio companies reach scale in technology sectors.

Pfizer is a leading global biopharmaceutical company that discovers, develops, manufactures, and markets medicines and vaccines to address unmet medical needs. It maintains a broad portfolio across prescription medicines, vaccines, and treatments spanning internal medicine, inflammation and immunology, oncology, and other therapeutic areas, and it operates a sizable pipeline of investigational products with potential to address major diseases. The company conducts extensive global sales, with international markets contributing a substantial share of revenue, and it emphasizes scientific innovation, transparency, patient access, and ethical business practices. Its well-known products include Prevnar 13 and Eliquis, among others, and it continues to invest in research and development to advance new therapies. Based in the United States, Pfizer has a long history dating back to the 19th century and maintains a global footprint through manufacturing, partnerships, and philanthropic initiatives aimed at improving health outcomes worldwide.

seed + speed Ventures is a venture capital firm that focuses on seed investments in B2B software startups. It has offices in Berlin, Munich, Hanover, and San Francisco and is part of the Maschmeyer Group. The firm backs pre-seed to seed-stage B2B software companies in Germany, Switzerland, and Austria. It provides equity investments and sales support to portfolio companies. Typical ticket sizes range from EUR 50,000 to EUR 500,000, with follow-on funding available up to EUR 1 million. Founded in 2016, the firm concentrates on early-stage software companies in the DACH region.

Wille Finance is a Swiss-based family office and investment platform established in 2007. Based in Zug, it provides tailored wealth management and makes direct investments across private equity, venture capital and buyouts, real estate, and listed assets, aiming for long-term value creation. The firm emphasizes an entrepreneurial approach and close client relationships, with governance managed by an executive team. It is described as a Swiss-based family office and investment platform that combines private market and liquid investments for sophisticated clients.

Forestay Capital is an early-growth venture capital firm focusing on enterprise software, artificial intelligence, and data-driven technology. It provides growth capital to revenue-generating companies at inflection points, supporting them from early revenue stages to market leadership. The firm targets enterprise AI, SaaS, data infrastructure, cybersecurity, productivity, and automation sectors across Europe, Israel, and the East Coast of the United States. It operates with offices in London and Geneva and is part of the B-FLEXION group. Forestay emphasizes rigorous due diligence and adds value from day one, leveraging sector expertise to help portfolio companies scale within five years.

Lakestar is a Zurich-based venture capital firm that backs technology companies led by ambitious entrepreneurs. Founded in 2012, it invests across Europe and the United States in deep tech, digitalization, artificial intelligence, fintech and healthcare, backing companies from seed to growth stages. Early investments included Skype, Spotify, Facebook and Airbnb, and the firm has since built a broad portfolio with names such as Revolut, GetYourGuide, Glovo, Hometogo, Oscar, Opendoor and others. Lakestar maintains a presence in Berlin, Zurich and London and supports portfolio companies with business development, recruitment, technology and marketing to help them enter new markets and scale internationally. The firm manages substantial capital across multiple funds and focuses on enabling growth through strategic guidance and network building in the European technology ecosystem.

VP Venture Partners is a Zurich-based venture capital firm established in 2020 that invests in early-stage life sciences companies across Europe, with a focus on medical devices, diagnostics, and digital health. It targets deep tech ventures in human life sciences and seeks unmet patient needs. The firm differentiates itself by providing hands-on support, including coaching, operational assistance, and, when needed, taking C-level positions or board seats to accelerate growth. It operates the Soglio Innovation Catalyst bootcamp, a three-day program designed to translate academic innovations into commercial opportunities by addressing IP, regulatory, and financing considerations. The team comprises experienced scientists and entrepreneurs committed to advancing healthcare startups from invention to impact.

Wellington Partners is a European venture capital firm headquartered in Munich with offices in London and Zurich. Established in 1998, it invests in early-stage and growth-stage technology and life sciences companies across Europe, with focus areas including digital health, software, electronics and photonics, resource efficiency, therapeutics, medical devices, diagnostics and industrial biotechnology. The firm provides resources to entrepreneurs to fund their strategies and typically leads financing rounds ranging from €0.5 million to €20 million, with its own commitment up to €15 million depending on the maturity of the company.

DART Ventures is a Zurich-based venture capital firm that backs early-stage startups in health and climate technologies across the United States and Europe. It invests in B2B, health technology, health consumer tech, food tech, clean tech, and climate tech ventures, with a focus on patient-centric AI, decarbonization, and energy transition. The firm runs a 12-month tailored expansion program that provides strategic guidance on growth, culture, fundraising, and go-to-market, leveraging experienced partners and networks to help portfolio companies expand in the US. DART Ventures emphasizes founder alignment of purpose and profit and seeks to connect portfolio companies with US investors and board members to support scale.

DIventures is a venture capital firm that supports and accelerates FinTech and RegTech innovations and trends.

DAA Capital Partners is a Geneva-based venture capital firm founded in 2018. It invests in early-stage and later-stage technology companies across Europe, with a focus on France, Germany, and Switzerland. The firm targets business-to-business and technology-driven sectors, including information technology, e-commerce, software as a service, manufacturing, Internet of Things, augmented reality, artificial intelligence, machine learning, big data, and real estate technology, and it also backs firms in automation and immersive technologies.

Invision is a Swiss private equity firm based in Zug that focuses on growth investments in Europe. Founded in 1997, it backs growth-oriented mid-market companies across healthcare, information technology, software, education, consumer and luxury goods, e-commerce, and industrial services. The firm pursues expansion capital and buyouts to accelerate growth, often engaging closely with management to implement strategic initiatives and build long-term value. With operations in Switzerland and Germany, Invision seeks to partner with owners and management to enable sustainable growth and successful ownership transitions, delivering returns for investors and stakeholders.

Nivalis Group is a venture capital firm and technology accelerator based in Villaz-Saint-Pierre, Switzerland. Founded in 2002, it invests in early-stage startups in information technology, artificial intelligence, advanced manufacturing, autonomous vehicles, robotics and drones, as well as automation and additive manufacturing. The firm provides capital, strategic guidance and human capital, helping startups progress from concept to product and market launch. It supports portfolio companies through product development, testing and market expansion, and leverages its Le Vivier technology park to foster collaboration. Nivalis Group accelerates international growth by drawing on engineering expertise and a network of industrial partners and co-investors, guiding ventures toward profitable exits when ready. The firm focuses on high-growth tech with an emphasis on engineering-driven solutions in automation, robotics, AI and manufacturing.

Bernina BioInvest is a venture capital firm based in Zug, Switzerland, founded in 2019. It targets early-stage biotech and medtech companies, providing capital and strategic guidance to support the development of innovative therapies and technologies that could improve patient outcomes and advance healthcare.

OCCIDENT is a Munich-based venture capital firm that backs deep-tech start-ups, with a focus on spin-offs from scientific research. The firm invests its own capital from the seed stage and maintains a long-term, hands-on approach, providing financial support and operational guidance to portfolio companies in life sciences and industrial tech from early development onward. With offices in Munich and Zug, OCCIDENT aims to create sustainable value and a positive societal impact through its investments by partnering closely with founders to translate scientific advances into practical solutions.

āltitude is a pan-European early-stage venture capital firm with bases in Berlin and offices in London and Zurich. It makes pre-seed and seed investments in startups that accelerate the digital transformation of small and medium-sized enterprises, with a focus on SME tech across Europe. The firm supports startups to drive efficiency and growth for SMEs through digital solutions and has launched SME Tech Leaders, a community for founders and operators building digital solutions for European SMEs.

Cape Capital is an independent wealth manager headquartered in Zurich, Switzerland, founded in 2002. It provides bespoke advisory and investment solutions to individuals and families, combining tailored financial guidance with access to exclusive private equity opportunities and a suite of in-house and selected third‑party funds to build personalised portfolios. The firm manages assets through active, risk-aware asset allocation across cash, fixed income, credit, equity, and private markets, and integrates sustainability and governance considerations into its client-focused approach.

Exelixis Capital is a venture capital firm based in Zurich, Switzerland. Founded in 2021, it seeks to invest in longevity, circular economy, and exponential technologies.

Planven is a Zurich-based venture capital firm that invests in European technology companies. It focuses on artificial intelligence, big data, software-as-a-service, cybersecurity, and health technology, with a particular emphasis on B2B markets. Planven supports its portfolio through strategic guidance and growth capital, helping companies scale rapidly and shape the evolving technology landscape.

L1D is a venture capital firm based in Zurich, Switzerland, focusing on digital assets, cryptocurrency, and blockchain technology sectors. Founded in 2018, the firm pursues opportunities in the blockchain ecosystem and utilizes a multi-strategy approach that includes event-driven, long/short, and fundamental equity strategies to assess value and manage risk.

TiVenture is a seed investment fund and venture capital firm based in Lugano, Switzerland. It is owned by the Fondazione Centenario Banca Stato and concentrates on early-stage companies with innovative technologies in southern Switzerland, focusing on life sciences, medical, high-tech, and information technology sectors. The firm offers hands-on coaching and mentoring to startups and collaborates with Agire, local universities, and the state government to support growth, diversification, and innovation in the Ticino economy. TiVenture maintains a diversified portfolio of early-stage companies pursuing scalable products for the global market.

Rosetta Capital is a UK-based venture capital and private equity firm that specializes in direct secondary investments in life sciences and healthcare companies. With more than twenty years of activity, the firm provides liquidity to investors and capital for follow-on financings while building and supporting healthcare businesses through strategic engagement. It targets opportunities in life sciences, medical devices, biotechnology, and pharmaceuticals, and pursues investments across Europe, North America, and Asia. Headquartered in Haddenham, United Kingdom, Rosetta Capital maintains additional offices in London and Switzerland to support a global investment approach. The firm is known for practical, outcome-focused involvement and has a history of successful exits, including initial public offerings and trade sales, reflecting its emphasis on value creation in the healthcare sector.

Global Founders Capital is a Berlin-based global venture capital platform that invests in early-stage technology companies with high growth potential. Founded in 2013 and backed by Rocket Internet, it operates across global markets with a stage-agnostic approach, supporting entrepreneurs from initial development through scale. The firm concentrates on software and TMT sectors, seeking exceptional founders with scalable ideas and providing backing to help companies grow, thrive, and reach global markets. It emphasizes identifying and nurturing innovative technology businesses worldwide and evaluating opportunities based on potential impact and feasibility.

FiveT Group is a Swiss investment holding company established in 2006 that builds a diversified portfolio across energy, digitization of financial services, technology, and life sciences to deliver impact through strategic investments and partnerships. The group operates through subsidiaries including FiveT Fintech, the venture capital arm founded in 2018 that backs fintech and healthcare startups developing technologies such as blockchain and machine learning, and FiveT Capital, an asset management arm licensed to offer asset management services in Switzerland, specializing in equity linked funds and tailored hedging solutions with a focus on sectors such as nuclear, cleantech, and life sciences in public markets.

Helsana is a leading Swiss health and accident insurer based in Zurich. It offers basic and supplementary health coverage to individuals and businesses and provides prevention services. The company combines digital tools with personal consultations, operating online services and maintaining a network of locations across Switzerland to support customers in managing health and insurance needs. Helsana aims to simplify navigating the insurance landscape, including coverage for accident benefits such as lump-sum payments, and emphasizes customer satisfaction through a comprehensive approach to health protection.

Forbion is a venture capital firm based in Naarden, Netherlands, with over twenty years of experience investing in biotech and life sciences. It focuses on human health, planetary health, and the bioeconomy, supporting early-stage and growth investments across Europe and North America in drug development, MedTech, and sustainable solutions. Its portfolio includes gene therapy and other innovative therapies for rare diseases. Forbion manages funds totaling about €5 billion in committed capital across multiple vehicles and prioritizes ESG principles in its investment approach, seeking to accelerate scientific advances and drive long-term value for portfolio companies.